Pulmonary neuroendocrine tumors

Surgical Pathology Clinics

Volumn 3, Issue 1, 2010, Pages 27-59

  Litzky, Leslie A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Atypical carcinoid tumor; Carcinoid tumor; Large cell neuroendocrine carcinoma; Neuroendocrine cell hyperplasia; Neuroendocrine tumors; Nonneuroendocrine cell carcinomas; Small cell carcinoma

Indexed keywords

CELL HYPERPLASIA; FROZEN SECTION; LUNG BIOPSY; LUNG SMALL CELL CANCER; LUNG TUMOR; MICROSCOPY; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PULMONARY NEUROENDOCRINE TUMOR; REVIEW;

EID: 77954479686     PISSN: 18759181     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.path.2010.03.007     Document Type: Review

References (41)

1. Travis W.D., Brambilla E., Müller-Hermelink H.K., et al. Pathology and genetics: tumours of the lung, pleura, thymus and heart 2004, IARC, Lyon (France).
2. Travis W.D., Colby T.V., Corrin B., et al. Histological typing of lung and pleural tumours 1999, Springer, Berlin. 3rd edition.
3. Moran C.A., Suster S., Coppola D., et al. Neuroendocrine carcinomas of the lung: a critical analysis. Am J Surg Pathol 2009, 131(2):206-221.
4. Travis W.D. Lung tumours with neuroendocrine differentiation. Eur J Cancer 2009, 45(Suppl 1):251-266.
5. Flieder D.B. Neuroendocrine tumors of the lung: recent developments in histopathology. Curr Opin Pulm Med 2002, 8:275-280.
6. Asamura H., Kameya T., Matsuno Y., et al. Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 2006, 24:70-76.
7. Dishop M.L., Kuruvilla S. Primary and metastatic lung tumors in the pediatric population: a review and 25-year experience at a large children's hospital. Arch Pathol Lab Med 2008, 132(7):1079-1103.
8. Fink G., Krelbaum T., Yellin A., et al. Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest 2001, 119:1647-1651.
9. Beasley M.B., Thunnissen F.B., Brambilla E., et al. Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum Pathol 2000, 31:1255-1265.
10. Deb S.J., Nichols F.C., Allen M.S., et al. Pulmonary carcinoid tumors with Cushing's syndrome: an aggressive variant or not?. Ann Thorac Surg 2005, 79(4):1132-1136.
11. Gustafsson B.I., Kidd M., Chan A., et al. Bronchopulmonary neuroendocrine tumors. Cancer 2008, 113(1):5-21.
12. Matoso A., Singh K., Jacob R., et al. Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors. Appl Immunohistochem Mol Morphol 2010, 18(2):142-149.
13. Lim E., Goldstraw P., Nicholson A.G., et al. Proceedings of the IASLC international workshop on advances in pulmonary neuroendocrine tumors. J Thorac Oncol 2007, 3(10):1194-1201.
14. Thomas C.F., Tazelaar H.D., Jett J.R. Typical and atypical pulmonary carcinoids: outcome in patients presenting with regional lymph node involvement. Chest 2001, 119(4):1143-1150.
15. Garcia-Yuste M., Matilla J.M., Cueto A., et al. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish multi-centric study of neuroendocrine tumours of the lung. Eur J Cardiothorac Surg 2007, 31(2):192-197.
16. Travis W.D., Rush W., Flieder D.B., et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid tumor and its separation from typical carcinoid. Am J Surg Pathol 1998, 22:934-944.
17. Ishida T., Yokoyama H., Sugio K., et al. Carcinoid tumor of the lung: clinicopathological and immunohistochemical studies. Eur J Surg Oncol 1992, 18:180-187.
18. Miller R.R., Muller N.L. Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors. Am J Surg Pathol 1995, 19:653-658.
19. Rizvi S.M., Goodwill J., Lim E., et al. The frequency of neuroendocrine cell hyperplasia in patients with pulmonary neuroendocrine tumours and non-neuroendocrine cell carcinomas. Histopathology 2009, 55(3):332-337.
20. Oliveira A.M., Tazelaar H.D., Myers J.L., et al. Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Am J Surg Pathol 2001, 25(6):815-819.
21. Cai Y.C., Banner B., Glickman J., et al. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Hum Pathol 2001, 32:1087-1093.
22. Du E.Z., Goldstraw P., Zacharias J., et al. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1 positive carcinoids are predominantly in peripheral location. Hum Pathol 2004, 35(7):825-831.
23. Srivastava A., Hornick J.L. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors. Am J Surg Pathol 2009, 33:626-632.
24. Sica G., Wagner P.L., Altorki N., et al. Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors. Arch Pathol Lab Med 2008, 132(12):1889-1895.
25. Vollmer R.T. Primary lung cancer vs. metastatic breast cancer: a probabilistic approach. Am J Clin Pathol 2009, 132(3):391-395.
26. Govindan R., Page N., Morgensztern D., et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006, 24(28):4539-4544.
27. Shepard F.A., Crowley J., Van H.P., et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007, 2(12):1067-1077.
28. Nicholson S.A., Beasley M.B., Brambilla E., et al. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol 2002, 26(9):1184-1197.
29. Butnor K.J., Beasley M.B., Cagle P.T., et al. Protocol for the examination of specimens from patients with primary non-small cell carcinoma, small cell carcinoma, or carcinoid tumor of the lung. Arch Pathol Lab Med 2009, 133:1552-1559.
30. Travis W.D., Gal A.A., Colby T.V., et al. Reproducibility of neuroendocrine lung tumor classification. Hum Pathol 1998, 29(3):272-279.
31. Pelosi G., Rodriguez J., Viale G., et al. Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients. Am J Surg Pathol 2005, 29(2):179-187.
32. Guinee D.G., Fishback N.F., Koss M.N., et al. The spectrum of immunohistohcemical staining of small-cell carcinoma in specimens from transbronchial and open lung biopsies. Cancer 1994, 102:406-414.
33. Kontogianni K., Nicholson A.G., Butcher D., et al. CD56: a useful tool for the diagnosis of small cell lung carcinomas on biopsies with extensive crush artifact. J Clin Pathol 2005, 58(9):978-980.
34. Agoff S.N., Lamps L.W., Philip A.T., et al. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol 2000, 13:238-242.
35. Travis W.D., Linnolia R.I., Tsokos M.G., et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma: an ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 1991, 15:529-533.
36. Iyoda A., Hiroshima K., Moriya Y., et al. Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma. J Thorac Cardiovasc Surg 2006, 132:312-315.
37. Marchevsky A.M., Gal A.A., Shah S., et al. Morphometry confirms the presence of considerable nuclear size overlap between 'small cells' and 'large cells' in high-grade pulmonary neuroendocrine neoplasms. Am J Clin Pathol 2001, 116:466-472.
38. Sica G., Vazquez M.F., Altorki N., et al. PAX-5 expression in pulmonary neuroendocrine neoplasms: its usefulness in surgical and fine-needle aspiration biopsy specimens. Am J Clin Pathol 2008, 129(4):556-562.
39. Gupta R., Dastane A., McKeena R.J., et al. What can we learn from the errors in the frozen section diagnosis of pulmonary carcinoid tumors? An evidence-based approach. Hum Pathol 2009, 40(1):1-9.
40. Travis W.D., Giroux D.J., Chansky K., et al. The IASLC lung cancer staging project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2008, 3(11):1213-1223.
41. Lim E., Blecher E., Yap Y.K., et al. The role of surgery in the treatment of limited disease small cell lung cancer: time to reevaluate. J Thorac Oncol 2008, 3(11):1267-1271.